Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Search & Filter

Enter one or more words in to the search box and press Enter.
With each additional filter selection requires the articles to have each of the categories selected.

  • Filter by Section

  • Filter by Author

Promote your brand

October 6, 2022
admin
Read more...--------------------------- This content is restricted to members of Pavilion Health Today. If you are […]

More than a million people could benefit from lifestyle tips and avoid type 2 diabetes

October 6, 2022
admin
People at the highest risk of type 2 diabetes should be given intensive exercise and weight loss help by the NHS, according to NICE.

DEVOTE trial shows lower rates of severe hypoglycaemia are associated with reduced risk of death

October 6, 2022
admin
A new post-hoc analyses from the DEVOTE trial showing that people with type 2 diabetes at high risk of cardiovascular disease who experience severe hypoglycaemia are at greater risk of death.

Suspect endometriosis in women with chronic pelvic pain, says NICE

November 23, 2022
admin
Delayed diagnosis is a significant problem for women with endometriosis, NICE has said, as new guidance aims to raise awareness among healthcare professionals.

GPs urged to look out for patients with a missed diagnosis ADHD, NICE has warned

May 2, 2023
Robert Mair
NICE is urging doctors to think about a potential ADHD diagnosis in people who are at higher risk of having the condition, but who are usually overlooked.

The number of written complaints about the NHS up by nearly 5 per cent

October 7, 2022
admin
There were 208,400 written complaints received by the NHS during 2016/172 €“ up 4.9% on the previous year, new NHS Digital figures reveal.

Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients

October 6, 2022
admin
The majority of patients with type 1 diabetes who were treated with dapagliflozin, a sodium glucose cotransporter-2 inhibitor (SGLT-2) used to treat type 2 diabetes, had a significant decline in their blood sugar levels, according to a new study.

Immunotherapy and targeted drugs could stop melanomas from returning

October 6, 2022
admin
Treatments used for some advanced melanomas could be effective in people with earlier stage disease after surgery, according to results from two clinical trials.

HRT can slow decline in lung function for middle-aged women

October 6, 2022
admin
Hormone replacement therapy (HRT) can slow the decline in lung function in middle-aged women, according to new research presented at the European Respiratory Society International Congress.

Keyhole oesophageal cancer surgery as good as more invasive operations

October 6, 2022
admin
Keyhole surgery for oesophageal cancer is as good as more invasive surgery in terms of survival, according to clinical trial results. 

Rethinking serotonin could lead to a shift in psychiatric care

October 6, 2022
admin
A better understanding of how serotonin, a neurotransmitter which helps brain cells communicate with one another, could lead to a radical shift in psychiatric care, according to a new paper.

Study offers a new mindset in the search for stroke therapies

October 6, 2022
admin
Researchers have identified a promising new avenue to explore in the search for stroke treatments, after translating findings from Alzheimer's disease.

Data analysis highlights protective effect of Edoxaban against stroke

October 6, 2022
admin
Edoxaban (Lixiana) provides comparable efficacy and greater safety compared to warfarin, sub-analysis data presented at the European Society of Cardiology Congress in Barcelona, Spain, has revealed.

Drinking four cups of coffee a day could reduce mortality risk

October 6, 2022
admin
Higher coffee consumption is associated with a lower risk of death, according to research presented at the ESC Congress. 

Marriage improves survival rate from heart disease

October 7, 2022
admin
Marriage is a vital factor affecting the survival of patients who have had a heart attack, as well as the survival of patients with the most important risk factors, according to research presented today at ESC Congress.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy